Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications
dc.contributor.author | Sun, X | |
dc.contributor.author | Huang, X | |
dc.contributor.author | Park, KS | |
dc.contributor.author | Zhou, X | |
dc.contributor.author | Kennedy, AA | |
dc.contributor.author | Pretto, CD | |
dc.contributor.author | Wu, Q | |
dc.contributor.author | Wan, Z | |
dc.contributor.author | Xu, Y | |
dc.contributor.author | Gong, W | |
dc.contributor.author | Sexton, JZ | |
dc.contributor.author | Tai, AW | |
dc.contributor.author | Lei, YL | |
dc.contributor.author | Moon, JJ | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-05-10T14:06:59Z | |
dc.date.available | 2024-05-10T14:06:59Z | |
dc.date.issued | 2024-04-16 | |
dc.identifier.issn | 1936-0851 | |
dc.identifier.issn | 1936-086X | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/38567994 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/193116 | en |
dc.description.abstract | The cGAS-STING pathway plays a crucial role in innate immune activation against cancer and infections, and STING agonists based on cyclic dinucleotides (CDN) have garnered attention for their potential use in cancer immunotherapy and vaccines. However, the limited drug-like properties of CDN necessitate an efficient delivery system to the immune system. To address these challenges, we developed an immunostimulatory delivery system for STING agonists. Here, we have examined aqueous coordination interactions between CDN and metal ions and report that CDN mixed with Zn2+ and Mn2+ formed distinctive crystal structures. Further pharmaceutical engineering led to the development of a functional coordination nanoparticle, termed the Zinc-Mn-CDN Particle (ZMCP), produced by a simple aqueous one-pot synthesis. Local or systemic administration of ZMCP exerted robust antitumor efficacy in mice. Importantly, recombinant protein antigens from SARS-CoV-2 can be simply loaded during the aqueous one-pot synthesis. The resulting ZMCP antigens elicited strong cellular and humoral immune responses that neutralized SARS-CoV-2, highlighting ZMCP as a self-adjuvant vaccine platform against COVID-19 and other infectious pathogens. Overall, this work establishes a paradigm for developing translational coordination nanomedicine based on drug-metal ion coordination and broadens the applicability of coordination medicine for the delivery of proteins and other biologics. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | American Chemical Society (ACS) | |
dc.subject | STING | |
dc.subject | cancer immunotherapy | |
dc.subject | coordination nanoparticle | |
dc.subject | cyclic dinucleotide | |
dc.subject | vaccine | |
dc.subject | Animals | |
dc.subject | Mice | |
dc.subject | Neoplasms | |
dc.subject | Adjuvants, Immunologic | |
dc.subject | Immunotherapy | |
dc.subject | Vaccines | |
dc.subject | Nanoparticles | |
dc.title | Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications | |
dc.type | Article | |
dc.identifier.pmid | 38567994 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/193116/2/Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications.pdf | |
dc.identifier.doi | 10.1021/acsnano.3c11374 | |
dc.identifier.doi | https://dx.doi.org/10.7302/22761 | |
dc.identifier.source | ACS Nano | |
dc.description.version | Published version | |
dc.date.updated | 2024-05-10T14:06:55Z | |
dc.identifier.orcid | 0000-0001-5977-2185 | |
dc.identifier.orcid | 0000-0002-9244-5888 | |
dc.identifier.orcid | 0000-0002-6877-450X | |
dc.identifier.orcid | 0000-0002-9868-9824 | |
dc.identifier.orcid | 0000-0003-2238-2372 | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 15 | |
dc.identifier.startpage | 10439 | |
dc.identifier.endpage | 10453 | |
dc.identifier.name-orcid | Sun, X | |
dc.identifier.name-orcid | Huang, X | |
dc.identifier.name-orcid | Park, KS | |
dc.identifier.name-orcid | Zhou, X; 0000-0001-5977-2185 | |
dc.identifier.name-orcid | Kennedy, AA | |
dc.identifier.name-orcid | Pretto, CD | |
dc.identifier.name-orcid | Wu, Q | |
dc.identifier.name-orcid | Wan, Z | |
dc.identifier.name-orcid | Xu, Y | |
dc.identifier.name-orcid | Gong, W | |
dc.identifier.name-orcid | Sexton, JZ; 0000-0002-9244-5888 | |
dc.identifier.name-orcid | Tai, AW; 0000-0002-6877-450X | |
dc.identifier.name-orcid | Lei, YL; 0000-0002-9868-9824 | |
dc.identifier.name-orcid | Moon, JJ; 0000-0003-2238-2372 | |
dc.working.doi | 10.7302/22761 | en |
dc.owningcollname | Pharmacy, College of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.